RenovoRx To Announce Promising New Clinical Data Using its TAMP™ Therapy Platform in an Abstract to be Presented at ASCO GI 2026

New Pharmacokinetic (PK) and Pharmacodynamic Data from Sub-Study in Phase III Trial Strengthens Scientific Basis for RenovoRx ...

Tempus Announces Eight Abstracts Accepted for Presentation at the 2026 ASCO® Gastrointestinal Cancers Symposium

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced ...
News Medical

AI vs. human: Study shows ChatGPT falls short in accuracy and authenticity of scientific abstracts

In a recent study published in Npj Digital Medicine, researchers compare abstracts from studies published in high-impact medical journals with abstracts developed using the artificial intelligence (AI ...
News Medical

AI in healthcare shows promise in trials but needs real-world testing to ensure effectiveness

In a recent study published in the journal The Lancet Digital Health, scientists in the United States evaluated the efficacy and challenges of artificial intelligence (AI) in clinical practice by ...